Ozempic generic approved in Canada after Novo Nordisk doesn’t pay $250 government fee
Bioethics Pundit
(BMJ) – Canada has become only the second country in the world to approve a generic form of the blockbuster drug Ozempic (semaglutide), made possible after its manufacturer, Novo Nordisk, did not pay a $C250 annual fee. Two generic versions … Read More